Evidence map›Paper›PMID 18588689›Full record

ArticleBMC medical genetics2008

Linkage disequilibrium mapping of a breast cancer susceptibility locus near RAI/PPP1R13L/iASPP.

Bjørn A Nexø, Ulla Vogel, Anja Olsen, Mette Nyegaard, Zuzanna Bukowy, Eszter Rockenbauer, Xiuqing Zhang, Cemile Koca, Mette Mains, Bettina Hansen and 9 more

Open access · goldAbstract read
In one paragraph

Article in BMC medical genetics, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Frontiers in genetics · 2021
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. In vitro effect of iASPP on cell growth of oral tongue squamous cell carcinoma.Chinese journal of cancer research = Chung-kuo yen cheng yen chiu · 2014
    Article
  9. MicroRNA124 regulate cell growth of prostate cancer cells by targeting iASPP.International journal of clinical and experimental pathology · 2014
    Article
  10. Article
  11. PPP1R13L variant associated with prognosis for patients with rectal cancer.Journal of cancer research and clinical oncology · 2013
    Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 9 institutions in 4 countries.

Bjørn A NexøInstitute of Human Genetics, University of Aarhus, DK-8000 Aarhus C, Denmark. nexo@humgen.au.dk
Ulla Vogel
Anja Olsen
Mette Nyegaard
Zuzanna Bukowy
Eszter Rockenbauer
Xiuqing Zhang
Cemile Koca
Mette Mains
Bettina Hansen
Anne Hedemand
Anette Kjeldgaard
Magdalena J Laska
Ole Raaschou-Nielsen
Søren Cold
Kim Overvad
Anne Tjønneland
Lars Bolund
Anders D Børglum
Aarhus University · DKDanish Cancer Society · DKAalborg University Hospital · DKBGI Group (China) · CNDepartment of Embryology · USInstitute of Biochemistry and Biophysics, Polish Academy of Sciences · PLNational Research Centre for the Working Environment · DKOdense University Hospital · DKRoskilde University · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPrevious results have suggested an association of the region of 19q13.3 with several forms of cancer. In the present study, we investigated 27 public markers within a previously identified 69 kb stretch of chromosome 19q for association with breast cancer by using linkage disequilibrium mapping. The study groups included 434 postmenopausal breast cancer cases and an identical number of individually matched controls. METHODS AND

resultsStudying one marker at a time, we found a region spanning the gene RAI (alias PPP1R13L or iASPP) and the 5' portion of XPD to be associated with this cancer. The region corresponds to a haplotype block, in which there seems to be very limited recombination in the Danish population. Studying combinations of markers, we found that two to four neighboring markers gave the most consistent and strongest result. The haplotypes with strongest association with cancers were located in the gene RAI and just 3' to the gene. Coinciding peaks were seen in the region of RAI in groups of women of different age. In a follow-up to these results we sequenced 10 cases and 10 controls in a 44 kb region spanning the peaks of association. This revealed 106 polymorphisms, many of which were not in the public databases. We tested an additional 44 of these for association with disease and found a new tandem repeat marker, called RAI-3'd1, located downstream of the transcribed region of RAI, which was more strongly associated with breast cancer than any other marker we have tested (RR = 2.44 (1.41-4.23, p = 0.0008, all cases; RR = 6.29 (1.49-26.6), p = 0.01, cases up to 55 years of age).

conclusionWe expect the marker RAI-3'd1 to be (part of) the cause for the association of the chromosome 19q13.3 region's association with cancer.

Indexed as

Linkage DisequilibriumBreast NeoplasmsChromosome MappingChromosomes, Human, Pair 19Cohort StudiesDenmarkFemaleGenetic MarkersGenetic Predisposition to DiseaseHumansIntracellular Signaling Peptides and ProteinsMiddle AgedPolymorphism, Single NucleotideRepressor ProteinsSequence Analysis, DNAGenetic MarkersIntracellular Signaling Peptides and ProteinsPPP1R13L protein, humanRepressor Proteins

Identifiers

PMID18588689
PMCPMC2474586
OpenAlexW2033189833

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.